RegenMedTX Overview
- Year Founded
-
2014

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
RegenMedTX General Information
Description
Developer of cell therapies for chronic kidney disease. The company develops cell therapy products that are programmed in the body to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organ.
Contact Information
Website
www.regenmedtx.comCorporate Office
- 3929 Westpoint Boulevard
- Suite G
- Winston-Salem, NC 27103
- United States
Corporate Office
- 3929 Westpoint Boulevard
- Suite G
- Winston-Salem, NC 27103
- United States
RegenMedTX Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 01-Mar-2016 | Completed | Startup | |||
1. Seed Round | 05-Aug-2015 | Completed | Startup |
RegenMedTX Comparisons
Industry
Financing
Details
RegenMedTX Competitors (3)
One of RegenMedTX’s 3 competitors is Nextera, a Venture Capital-Backed company based in Oslo, Norway.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Nextera | Venture Capital-Backed | Oslo, Norway | ||||
Akebia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
Genentech | Formerly VC-backed | South San Francisco, CA |
RegenMedTX Patents
RegenMedTX Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2010319385-A1 | Rational design of regenerative medicine products | Inactive | 12-Nov-2009 | ||
JP-2016187640-A | Tissue engineering scaffolds | Inactive | 14-Feb-2008 |
RegenMedTX Investments & Acquisitions (2)
RegenMedTX’s most recent deal was a Secondary Transaction - Private with Tengion. The deal was made on 01-Nov-2017.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Tengion | 01-Nov-2017 | Secondary Transaction - Private | Biotechnology | ||
Tengion | 06-Mar-2015 | Merger/Acquisition | Biotechnology |
RegenMedTX FAQs
-
When was RegenMedTX founded?
RegenMedTX was founded in 2014.
-
Where is RegenMedTX headquartered?
RegenMedTX is headquartered in Winston-Salem, NC.
-
What industry is RegenMedTX in?
RegenMedTX’s primary industry is Biotechnology.
-
Is RegenMedTX a private or public company?
RegenMedTX is a Private company.
-
What is RegenMedTX’s current revenue?
The current revenue for RegenMedTX is
. -
How much funding has RegenMedTX raised over time?
RegenMedTX has raised $4.37M.
-
Who are RegenMedTX’s competitors?
Nextera, Akebia Therapeutics, and Genentech are competitors of RegenMedTX.
-
When was RegenMedTX acquired?
RegenMedTX was acquired on 01-Mar-2016.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »